Usefulness of cumulative summation of differences method for determining APTT reagent suitability.

Susan H Findlater
{"title":"Usefulness of cumulative summation of differences method for determining APTT reagent suitability.","authors":"Susan H Findlater","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The Cumulative Summation of Differences (CUSUM) is a recommended method for determining the consistency of one lot of Activated Partial Thromboplastin Time (APTT) reagent to another. This study investigates the usefulness of the CUSUM as a primary method for determining reagent suitability for APTT testing.</p><p><strong>Method: </strong>Results for lot comparison, reference range and Ex-Vivo heparin sensitivity studies were obtained using the Beckman Coulter ACL TOP coagulation analyzer. APTT testing was performed using HemosIL SynthASiL w/CaCl and Heparin Xa testing was performed using the HemosIL Liquid Heparin Assay. Samples from normal patients and from patients taking heparin were tested.</p><p><strong>Results: </strong>The CUSUM calculation showed a difference in APTT reagent lot means that is within the acceptable range for this method, suggesting that the reagents were comparable. Reference range and heparin sensitivity studies demonstrated a clinically significant difference between the two reagent lot numbers tested.</p><p><strong>Conclusion: </strong>The CUSUM method of evaluating reagent lot variation of APTT reagents should be used with caution as it may not completely reflect the performance of the reagent. Clinically significant differences between reagent sensitivity may not be detected. The results of reference range and heparin sensitivity studies should also be considered when determining the suitability of APTT reagents. In addition, due to research evidence that using the APTT test for monitoring patient anticoagulation therapy is problematic, an evaluation of the benefits of using other study methods and multiple study methods is suggested as well as continued examination of the use of the APTT as the test of choice for UF heparin monitoring.</p>","PeriodicalId":72611,"journal":{"name":"Clinical laboratory science : journal of the American Society for Medical Technology","volume":"25 3","pages":"142-8"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory science : journal of the American Society for Medical Technology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The Cumulative Summation of Differences (CUSUM) is a recommended method for determining the consistency of one lot of Activated Partial Thromboplastin Time (APTT) reagent to another. This study investigates the usefulness of the CUSUM as a primary method for determining reagent suitability for APTT testing.

Method: Results for lot comparison, reference range and Ex-Vivo heparin sensitivity studies were obtained using the Beckman Coulter ACL TOP coagulation analyzer. APTT testing was performed using HemosIL SynthASiL w/CaCl and Heparin Xa testing was performed using the HemosIL Liquid Heparin Assay. Samples from normal patients and from patients taking heparin were tested.

Results: The CUSUM calculation showed a difference in APTT reagent lot means that is within the acceptable range for this method, suggesting that the reagents were comparable. Reference range and heparin sensitivity studies demonstrated a clinically significant difference between the two reagent lot numbers tested.

Conclusion: The CUSUM method of evaluating reagent lot variation of APTT reagents should be used with caution as it may not completely reflect the performance of the reagent. Clinically significant differences between reagent sensitivity may not be detected. The results of reference range and heparin sensitivity studies should also be considered when determining the suitability of APTT reagents. In addition, due to research evidence that using the APTT test for monitoring patient anticoagulation therapy is problematic, an evaluation of the benefits of using other study methods and multiple study methods is suggested as well as continued examination of the use of the APTT as the test of choice for UF heparin monitoring.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
差异累积求和法测定APTT试剂适宜性的有效性。
目的:累积差异求和法(CUSUM)是测定一批活化部分凝血酶活时间(APTT)试剂与另一批试剂一致性的推荐方法。本研究探讨了CUSUM作为确定APTT检测试剂适用性的主要方法的有效性。方法:采用Beckman Coulter ACL TOP凝血分析仪进行批次比较、参考范围和离体肝素敏感性研究。APTT检测采用haemsil SynthASiL /CaCl,肝素Xa检测采用haemsil液体肝素测定法。对正常患者和服用肝素患者的样本进行了检测。结果:CUSUM计算显示APTT试剂批次平均值的差异在本方法的可接受范围内,提示试剂具有可比性。参考范围和肝素敏感性研究证明了两种试剂批号测试之间的临床显著差异。结论:采用CUSUM方法评价APTT试剂批次变化,可能不能完全反映试剂的性能,应谨慎使用。可能无法检测到试剂敏感性之间的临床显著差异。在确定APTT试剂的适用性时,还应考虑参考范围和肝素敏感性研究的结果。此外,由于研究证据表明使用APTT检测监测患者抗凝治疗存在问题,因此建议对使用其他研究方法和多种研究方法的益处进行评估,并继续检查使用APTT作为UF肝素监测的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Laboratory Findings in Hematology, Clinical Chemistry, and Urinalysis for Patients With Thrombotic Thrombocytopenic Purpura The CF Quantum Sweat Test: Not Ready for Clinical Use The Efficacy and Acceptance of Brief Intentional Teachings to Encourage Success Virtual Learning: The Development of Case Study Based Lab Simulation in the Clinical Laboratory Science Undergraduate Curriculum Pilot Program in Clinical Microbiology Laboratory Simulation for MLS Students
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1